← Back to Search

Radiation Therapy

accelerated partial breast irradiation for Breast Cancer

N/A
Waitlist Available
Led By Imran Zoberi, M.D.
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 5 years
Awards & highlights

Study Summary

This trial studies how well a single session of radiation therapy works in treating patients with early stage breast cancer.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Proportion of patients who are free of breast cancer in the treated breast
Proportion of patients who are free of serious treatment related toxicity
Secondary outcome measures
Change in quality of life as measured by the EORTC QLC-C30
Change in quality of life as measured by the QLQ-BR23
Change in quality of life as measured by the Visual Analog Scale for Pain
+8 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment (HG-PBI)Experimental Treatment1 Intervention
Patients undergo single fraction high gradient-partial breast irradiation within 8 weeks after partial mastectomy.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
accelerated partial breast irradiation
2009
N/A
~190

Find a Location

Who is running the clinical trial?

Washington University School of MedicineLead Sponsor
1,933 Previous Clinical Trials
2,299,675 Total Patients Enrolled
47 Trials studying Breast Cancer
5,168 Patients Enrolled for Breast Cancer
Imran Zoberi, M.D.Principal InvestigatorWashington University School of Medicine
5 Previous Clinical Trials
326 Total Patients Enrolled
2 Trials studying Breast Cancer
207 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still vacancies available for those wishing to participate in this clinical trial?

"According to the information listed on clinicaltrials.gov, recruitment for this trial has concluded and it is not presently seeking applicants. This study was first posted in April of 2014 with its last update taking place November 14th 2022; however, there are over two thousand other trials currently recruiting patients."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer
2014. "Single Fraction High-Gradient Partial Breast Irradiation in Treating Patients With Low-Risk Stage 0-I Breast Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02076074.
~5 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top